Delivery Order SPE2DR25D3017-SPE2DR26F3EG8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,093.70 to AmerisourceBergen Drug Corp for the supply of Belbuca 750 microgram film (60 count) on December 3, 2025, with completion scheduled for December 4, 2025. This non-competitive delivery order represents a firm fixed price transaction utilizing a competitively awarded indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,045.41 to AmerisourceBergen Drug Corp for 60 units of Belbuca 600 microgram film on November 5, 2025, with completion scheduled for November 6, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,774.31 to AmerisourceBergen Drug Corp for 60 units of Belbuca 900 micrograms film on December 8, 2025, with completion scheduled for December 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Belbuca is a buccal film formulation used for opioid pain management in opioid-tolerant patients,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Belbuca 600 microgram films (60 count). This competitively awarded, non-set-aside delivery order carries a ceiling value of $2,683.50 with firm fixed pricing and an ultimate completion date of October 20, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,644.43 to AmerisourceBergen Drug Corp for Belbuca 300 mcg film (60 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, which is not set aside, represents a pharmaceutical supply delivery under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $1,168.12 delivery order to AmerisourceBergen Drug Corp for BELBUCA 750 MCG film (60 count) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively granted with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BELBUCA 900 MCG film (60 count) with a ceiling value of $1,791.88 under a firm fixed price contract type. This delivery order, awarded on August 29, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made through full and open competition with no set-aside designation. Performance will be completed at the...
- The Defense Logistics Agency awarded a delivery order valued at $1,061.52 to AmerisourceBergen Drug Corp for BELBUCA 300 MCG Film (60 count) on July 25, 2025, with completion expected by July 28, 2025. This is a firm fixed price, non-set-aside contract executed as a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The product is a buccal film formulation used for pain management, reflecting the company's role as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $2,615.72 firm fixed price delivery order to AmerisourceBergen Drug Corp for Belbuca 900 microgram films (60-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-competitive, non-set-aside award represents a small-value transaction typical of routine pharmaceutical supply replenishment. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $4,192.70 to AmerisourceBergen Drug Corp for BELBUCA 750 mcg Film, 60 count units, with delivery to the vendor's Conshohocken, Pennsylvania location. This competitively awarded, firm fixed-price delivery order was issued on April 24, 2025, with an ultimate completion date of April 25, 2025. BELBUCA is a transmucosal buccal film formulation used for opioid pain management in opioid-tolerant patients, representing a specialized...
- SPE2DR25D3017Indefinite Delivery Contract
- SPE2DR25D3017-SPE2DR26F3EG8Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,743.95 delivery order for Belbuca 600 microgram film (60 units) on December 4, 2025, with a completion date of December 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a transactional procurement under AmerisourceBergen's broader relationship with the federal government's medical supply chain. This award operates as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare operations globally, including support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Belbuca, a buccal film formulation used for opioid pain management in opioid-tolerant patients, exemplifies the specialized pharmaceutical products delivered under this contract framework to sustain the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/3/25 |